The Indian Pharmaceutical Market Will Grow Rapidly Owing To Increase Strength, Weakness, Opportunity and Threats In Pharmacitical Sector Till 2015: Radiant Insights.

This report discusses the Indian pharmaceutical industry in depth, with specific focus on the ten leading domestic India pharmaceutical companies; their key financials since FY2011; their key global markets; their Merger, Acquisition and Joint Venture activity; their Research & Development spending; as well as Strength, Weakness, Opportunity and Threats that each individual company faces. This report also offers a snapshot of the key financials in the India pharmaceutical sector; import / export values, and where the India based pharmaceutical companies are generating their revenue globally. The report concludes with interviews with directors of Ipca Laboratories, Cadila Healthcare and Cipla.

The Indian Pharmaceutical Market - Leading Domestic Companies 2015 also highlights what drives, or restrains, the market for these leading companies;

To Get Full Report Click Here @ http://www.radiantinsights.com/research/the-indian-pharmaceutical-market  

Key Drivers

US Generics Market

JV, Acquisitions & Mergers

Patent Cliff

Increased Domestic Health Spending

Geographic Expansion into Semi-Regulated and Emerging Pharma Markets

Economies in Drug Production/Manufacture

Governmental Support

Key Restraints

Industry Inefficiencies

Regulatory Non-Compliance

Price Ceilings

Intellectual Property Rights / Compulsory Licence

Inadequate Health Insurance, India

Read Complete Report With TOC @ http://www.radiantinsights.com/catalog/pharmaceutical

The US generics market has been a massive growth driver for the India pharmaceutical market, with many leading companies in GMR Data’s list generating over 50% of their annual revenues from the US generics market. However with access to the US market comes increased scrutiny from the US FDA; nearly all the companies in the top ten have faced warnings from the FDA; ranging from minor procedural infractions to complete manufacturing shutdown.

Table of Contents

1 Executive Summary

1.1 Executive Summary

1.2 Research and Analysis Methods

1.3 Drivers & Restraints

1.3.1 Drivers

1.3.1.1 US Generics Market

1.3.1.2 JV, Acquisitions & Mergers

1.3.1.3 Patent Cliff

1.3.1.4 Increased Domestic Health Spending

See More Reports of This Category by Radiant Insights:

·         Rheumatic Disorders Global Clinical Trials Review, H2, 2015 - http://www.radiantinsights.com/research/rheumatic-disorders-global-clinical-trials-review-h2-2015

·         Bone Defects Global Clinical Trials Review, H2, 2015 - http://www.radiantinsights.com/research/bone-defects-global-clinical-trials-review-h2-2015

1.3.1.5 Geographic Expansion into Semi-Regulated and Emerging Pharma Markets

1.3.1.6 Economies in Drug Production/Manufacture

1.3.1.7 Governmental Support

1.3.2 Restraints

1.3.2.1 Industry Inefficiencies and Regulatory Non-Compliance

1.3.2.2 Price Ceilings

1.3.2.3 Intellectual Property Rights / Compulsory Licence

1.3.2.4 Inadequate Health Insurance, India

2 Indian Pharmaceutical Market Overview

2.1 Evolution of the India Pharmaceutical Sector

2.1.1 Key Reforms/Regulations

2.1.2 Customers/End-Users

2.1.3 Pricing/Reimbursement

2.1.4 Competitive Landscape

3 India Pharmaceutical Market Revenue

3.1 Pharmaceutical Market Revenue - Domestic

3.2 Pharmaceutical Market Revenue – Export

3.3 Domestic Pharmaceutical Drugs Market Share

About Radiant Insights

Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. We assist and facilitate organizations and individuals procure market research reports, helping them in the decision making process. We have a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, our experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.

For More Information, Visit Radiant Insights

Contact:
Michelle Thoras
Corporate Sales Specialist, USA
Radiant Insights, Inc
Phone: 1-415-349-0054
Toll Free: 1-888-202-9519
Email: sales@radiantinsights.com